⌘K

Login Start Free

Home/Filings/4/0000899243-19-002708

4//SEC Filing

MAGRAB E. BRENDAN 4

Accession 0000899243-19-002708

CIK 0001042418other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:52 PM ET

Size

5.4 KB

Accession

0000899243-19-002708

Insider Transaction Report

Form 4

Period: 2019-02-03

HedgePath Pharmaceuticals, Inc.HPPI

MAGRAB E. BRENDAN

DirectorChairman of the Board

Transactions

Award
Common Stock Options
2019-02-03+986,842→ 986,842 total
Exercise: $0.08From: 2020-02-03Exp: 2029-02-03→ Common Stock (986,842 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

HedgePath Pharmaceuticals, Inc.

CIK 0001042418

Entity typeother

Related Parties

1

filerCIK 0001196062

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 7:52 PM ET
Size: 5.4 KB

View on SEC.gov